References
1. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev . 2009;89:381-410.
2. Argiles JM, Busquets S, Stemmler B and Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer . 2014;14:754-62.
3. Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM and Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle . 2020;11:619-635.
4. Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M and Rezaei N. Cancer cachexia: Diagnosis, assessment, and treatment.Crit Rev Oncol Hematol . 2018;127:91-104.
5. Ni J and Zhang L. Cancer Cachexia: Definition, Staging, and Emerging Treatments. Cancer Manag Res . 2020;12:5597-5605.
6. Mattox TW. Cancer Cachexia: Cause, Diagnosis, and Treatment.Nutr Clin Pract . 2017;32:599-606.
7. Argiles JM, Lopez-Soriano FJ, Stemmler B and Busquets S. Therapeutic strategies against cancer cachexia. Eur J Transl Myol . 2019;29:7960.
8. Montalvo RN, Counts BR and Carson JA. Understanding sex differences in the regulation of cancer-induced muscle wasting. Curr Opin Support Palliat Care . 2018;12:394-403.
9. Zhong X and Zimmers TA. Sex Differences in Cancer Cachexia.Curr Osteoporos Rep . 2020;18:646-654.
10. Rosa-Caldwell ME and Greene NP. Muscle metabolism and atrophy: let’s talk about sex. Biol Sex Differ . 2019;10:43.
11. Rausch V, Sala V, Penna F, Porporato PE and Ghigo A. Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia. Oncogenesis . 2021;10:1.
12. Yang W, Huang J, Wu H, Wang Y, Du Z, Ling Y, Wang W, Wu Q and Gao W. Molecular mechanisms of cancer cachexiainduced muscle atrophy (Review).Mol Med Rep . 2020;22:4967-4980.
13. Judge SM, Nosacka RL, Delitto D, Gerber MH, Cameron ME, Trevino JG and Judge AR. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival. JNCI Cancer Spectr . 2018;2:pky043.
14. Light N and Champion AE. Characterization of muscle epimysium, perimysium and endomysium collagens. Biochem J . 1984;219:1017-26.
15. Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA and Garry DJ. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics . 2003;14:261-71.
16. Devine RD, Bicer S, Reiser PJ, Velten M and Wold LE. Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia. Am J Physiol Heart Circ Physiol . 2015;309:H685-91.
17. Chakravarthy A, Khan L, Bensler NP, Bose P and De Carvalho DD. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun . 2018;9:4692.
18. Caja L, Dituri F, Mancarella S, Caballero-Diaz D, Moustakas A, Giannelli G and Fabregat I. TGF-beta and the Tissue Microenvironment: Relevance in Fibrosis and Cancer. Int J Mol Sci . 2018;19.
19. Tsuda T. Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-beta in Physiological and Pathological Conditions. Int J Mol Sci . 2018;19.
20. Alves MJ, Figueredo RG, Azevedo FF, Cavallaro DA, Neto NI, Lima JD, Matos-Neto E, Radloff K, Riccardi DM, Camargo RG, De Alcantara PS, Otoch JP, Junior ML and Seelaender M. Adipose tissue fibrosis in human cancer cachexia: the role of TGFbeta pathway. BMC Cancer . 2017;17:190.
21. White JP. IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm. Transl Cancer Res . 2017;6:S280-S285.
22. Mortreux M, Rosa-Caldwell ME, Stiehl ID, Sung DM, Thomas NT, Fry CS and Rutkove SB. Hindlimb suspension in Wistar rats: Sex-based differences in muscle response. Physiol Rep . 2021;9:e15042.
23. Rosa-Caldwell ME, Lim S, Haynie WS, Brown JL, Lee DE, Dunlap KR, Jansen LT, Washington TA, Wiggs MP and Greene NP. Mitochondrial aberrations during the progression of disuse atrophy differentially affect male and female mice. J Cachexia Sarcopenia Muscle . 2021;12:2056-2068.
24. Rosa-Caldwell ME, Lim S, Haynie WA, Brown JL, Deaver JW, Morena Da Silva F, Jansen LT, Lee DE, Wiggs MP, Washington TA and Greene NP. Female mice may have exacerbated catabolic signalling response compared to male mice during development and progression of disuse atrophy.J Cachexia Sarcopenia Muscle . 2021;12:717-730.
25. White JP, Baltgalvis KA, Sato S, Wilson LB and Carson JA. Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury. J Appl Physiol (1985) . 2009;107:1420-30.
26. Counts BR, Fix DK, Hetzler KL and Carson JA. The Effect of Estradiol Administration on Muscle Mass Loss and Cachexia Progression in Female Apc (Min/+) Mice. Front Endocrinol (Lausanne) . 2019;10:720.
27. Lim S, Deaver JW, Rosa-Caldwell ME, Haynie WS, Morena da Silva F, Cabrera AR, Schrems ER, Saling LW, Jansen LT, Dunlap KR, Wiggs MP, Washington TA and Greene NP. Development of metabolic and contractile alterations in development of cancer cachexia in female tumor-bearing mice. J Appl Physiol (1985) . 2022;132:58-72.
28. Brown JL, Rosa-Caldwell ME, Lee DE, Blackwell TA, Brown LA, Perry RA, Haynie WS, Hardee JP, Carson JA, Wiggs MP, Washington TA and Greene NP. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.J Cachexia Sarcopenia Muscle . 2017;8:926-938.
29. Brown JL, Lee DE, Rosa-Caldwell ME, Brown LA, Perry RA, Haynie WS, Huseman K, Sataranatarajan K, Van Remmen H, Washington TA, Wiggs MP and Greene NP. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice. J Cachexia Sarcopenia Muscle . 2018;9:987-1002.
30. Perry RA, Brown LA, Haynie WS, Brown JL, Rosa-Caldwell ME, Lee DE, Greene NP and Washington TA. Cardiac hypertrophy in sarcopenic obese C57BL/6J mice is independent of Akt/mTOR cellular signaling.Experimental gerontology . 2018;111:122-132.
31. Goossens GH, Jocken JWE and Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.Nat Rev Endocrinol . 2021;17:47-66.
32. Nye GA, Sakellariou GK, Degens H and Lightfoot AP. Muscling in on mitochondrial sexual dimorphism; role of mitochondrial dimorphism in skeletal muscle health and disease. Clin Sci (Lond) . 2017;131:1919-1922.
33. Fernandes LG, Tobias GC, Paixao AO, Dourado PM, Voltarelli VA and Brum PC. Exercise training delays cardiac remodeling in a mouse model of cancer cachexia. Life Sci . 2020;260:118392.
34. Schmidt SF, Rohm M, Herzig S and Berriel Diaz M. Cancer Cachexia: More Than Skeletal Muscle Wasting. Trends Cancer . 2018;4:849-860.
35. Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact . 2018;292:76-83.
36. Walton KL, Johnson KE and Harrison CA. Targeting TGF-beta Mediated SMAD Signaling for the Prevention of Fibrosis. Front Pharmacol . 2017;8:461.
37. Ma TT and Meng XM. TGF-beta/Smad and Renal Fibrosis. Adv Exp Med Biol . 2019;1165:347-364.
38. Floege J. Antagonism of canonical Wnt/beta-catenin signaling: taking RAS blockade to the next level? J Am Soc Nephrol . 2015;26:3-5.
39. Qiao X, Rao P, Zhang Y, Liu L, Pang M, Wang H, Hu M, Tian X, Zhang J, Zhao Y, Wang XM, Wang C, Yu H, Guo F, Cao Q, Wang Y, Wang YM, Zhang GY, Lee VW, Alexander SI, Zheng G and Harris DCH. Redirecting TGF-beta Signaling through the beta-Catenin/Foxo Complex Prevents Kidney Fibrosis. J Am Soc Nephrol . 2018;29:557-570.
40. Guerrero F, Herencia C, Almaden Y, Martinez-Moreno JM, Montes de Oca A, Rodriguez-Ortiz ME, Diaz-Tocados JM, Canalejo A, Florio M, Lopez I, Richards WG, Rodriguez M, Aguilera-Tejero E and Munoz-Castaneda JR. TGF-beta prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/beta-catenin pathways. PLoS One . 2014;9:e89179.
41. Ma H, Wei Y, Leng Y, Li S, Gao L, Hu H, Chen L, Wang F, Xiao H, Zhu C and Liang C. TGF-beta1-induced expression of Id-1 is associated with tumor progression in gastric cancer. Med Oncol . 2014;31:19.